Why iSelect?

The American entrepreneur may be the single most effective wealth builder the world has ever known. By focusing on solving the world’s big problems in new and innovative ways, they have the potential to change millions of lives and generate tremendous profits doing so. Want affordable health care or improved education? Ask an entrepreneur. Want to improve crop yield or help farmers become more profitable? Ask an entrepreneur. Our economic resilience comes from consumers asking for better answers, entrepreneurs bold enough to think differently, and investors willing to fund new ventures.

iSelect supports the disruptive potential of emerging technologies that may substantially change markets. We believe in tapping the enormous promise of Agtech, Foodtech and healthcare innovation by offering financial advisors, qualified and accredited investors and family offices access to pre-IPO/pre-exit companies.

An investment in iSelect differs from traditional venture capital in three key ways:

  • Invest in a portfolio of 25+ startups through iSelect’s uniquely accessible venture capital strategies with lower minimums and fees than our competitors. Co-invest alongside name brand, global venture firms with the same terms.
  • Access the expertise of our full-time research and investment team, 175+ external advisors, and hundreds of investors with deep industry experience. Enjoy greater liquidity, optionality and lower fees when compared to more traditional venture funds.
  • Leverage a done-for-you fund of carefully vetted companies in growth industries like Agriculture, Nutrition, Personalized Medicine and Healthcare Technology.

iSelect has evaluates thousands of start-ups, carefully crafting a portfolio of companies we believe has the greatest chance to make a significant impact on food and health and create the potential for significant growth. Our deep network of external industry advisors provides expertise and insight in the areas we consider as part of a comprehensive due diligence process.


We believe that a diversified portfolio can achieve the best risk adjusted results for investors. Research and fund performance represented by the Kauffman Foundation, Cambridge Associates, and 500 Startups all reach the same conclusion. Modern portfolio theory teaches us that, by investing in more than one stock, an investor can reap the benefits of diversification – chief among these benefits is the potential for a reduction in the riskiness of the portfolio.iSelect sources and researches investment opportunities so its investors don’t have to.


Kauffman Foundation data clearly shows that success may also require extensive diligence and industry expertise. Further, the assets underpinning the venture must still be fundamentally valuable and the company’s progress monitored diligently. iSelect performs more than 120 hours of diligence on each deal within which we invest, leveraging expert Selection Committees in our investment review and actively monitoring company progress post-investment.

National Scope

Silicon Valley cultivates software, IT, media and entertainment ventures. But what about everything else? How can investors tap into the rest of America’s unique innovation engine? iSelect brings accredited and institutional investment to early-stage ventures in Chicago, Cleveland, Denver, Houston, Indianapolis, St. Louis and many more because that’s where we’re finding the best opportunities. We invest outside Silicon Valley because these locations offer lower operating costs, proximity to customers, excellent talent, rational valuations, and strong exit opportunities.


Join our mailing list